CB12 was developed at the University of Oslo's Faculty of Dentistry. The patented formula in CB12 neutralises the formation of the substances that cause unpleasant breath, called volatile sulphur compounds (VSCs).
Volatile sulphur compounds are unpleasant and odorous compounds that develop as a result of bacteria in the mouth that break down food particles in between the teeth, in the gum pockets and in the pits on the back of the tongue.
The neutralising action of CB12 is achieved by a powerful synergy between zinc acetate and chlorhexidine diacetate that is much more effective than either ingredient alone. Because of the amazing way these two ingredients work together, only a low concentration of each one is required.
Chlorhexidine splits the sulphur molecules, allowing zinc to more easily react with the sulphur compounds. In addition, it has an antibacterial effect against the bacterial membranes. The unique ability of chlorhexidine to adhere to the lining of the mouth, tongue and teeth ensures that CB12 maintains a long-lasting effect. Most importantly, the level of chlorhexidine is so low that staining does not occur.
Zinc is the most effective form of combatting VSCs. Zinc interacts with the split sulphur molecules building insoluble, non-odorous compounds that are spit out with the rinse or swallowed. In addition, it directly interferes with VSC production.